These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 23227847

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Oxidant-antioxidant status in Egyptian children with sickle cell anemia: a single center based study.
    El-Ghamrawy MK, Hanna WM, Abdel-Salam A, El-Sonbaty MM, Youness ER, Adel A.
    J Pediatr (Rio J); 2014; 90(3):286-92. PubMed ID: 24508012
    [Abstract] [Full Text] [Related]

  • 43. Assessment of some indicators of oxidative stress in nigerian sickle cell anemic patients.
    Okorie CP, Nwagha T, Ejezie F.
    Ann Afr Med; 2018; 17(1):11-16. PubMed ID: 29363630
    [Abstract] [Full Text] [Related]

  • 44. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
    Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E.
    Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789
    [Abstract] [Full Text] [Related]

  • 45. Study of correlation of nitrite levels with malonaldehyde and the prognosis of patients with sickle cell disease on hydroxyurea, Ceará-Brazil.
    Gonçalves RP, Elias DB, Magalhães HI, de Souza JH.
    J Clin Lab Anal; 2011 Sep; 25(5):369-73. PubMed ID: 21919074
    [Abstract] [Full Text] [Related]

  • 46. Iron in sickle cell disease.
    Das PK, Sarangi A, Satapathy M, Palit SK.
    J Assoc Physicians India; 1990 Nov; 38(11):847-9. PubMed ID: 2079471
    [Abstract] [Full Text] [Related]

  • 47. Therapy insight: metabolic and endocrine disorders in sickle cell disease.
    Smiley D, Dagogo-Jack S, Umpierrez G.
    Nat Clin Pract Endocrinol Metab; 2008 Feb; 4(2):102-9. PubMed ID: 18212812
    [Abstract] [Full Text] [Related]

  • 48. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
    Fung EB, Harmatz P, Milet M, Ballas SK, De Castro L, Hagar W, Owen W, Olivieri N, Smith-Whitley K, Darbari D, Wang W, Vichinsky E, Multi-Center Study of Iron Overload Research Group.
    Am J Hematol; 2007 Apr; 82(4):255-65. PubMed ID: 17094096
    [Abstract] [Full Text] [Related]

  • 49. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
    Jastaniah W, Harmatz P, Pakbaz Z, Fischer R, Vichinsky E, Walters MC.
    Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
    [Abstract] [Full Text] [Related]

  • 50. Serum melatonin level and oxidative stress in sickle cell anemia.
    Shimauti EL, Silva DG, de Almeida EA, Zamaro PJ, Belini Junior E, Bonini-Domingos CR.
    Blood Cells Mol Dis; 2010 Dec 15; 45(4):297-301. PubMed ID: 20888275
    [Abstract] [Full Text] [Related]

  • 51. Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease.
    Porter JB.
    Hemoglobin; 2009 Dec 15; 33 Suppl 1():S37-45. PubMed ID: 20001631
    [Abstract] [Full Text] [Related]

  • 52. Metabolic pathways related to oxidative stress in patients with hemoglobin h disease and iron overload.
    Chiou SS, Tsao CJ, Tsai SM, Wu YR, Liao YM, Lin PC, Tsai LY.
    J Clin Lab Anal; 2014 Jul 15; 28(4):261-8. PubMed ID: 24577940
    [Abstract] [Full Text] [Related]

  • 53. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A, Falda M, Manzini P, D'Antico S, Valfrè A, Locatelli F, Calabrese R, Chiappella A, D'Ardia S, Longo F, Piga A.
    Biol Blood Marrow Transplant; 2010 Jan 15; 16(1):115-22. PubMed ID: 19766730
    [Abstract] [Full Text] [Related]

  • 54. Iron incorporation in red blood cells of pediatric sickle cell anemia: a stable isotope pilot investigation.
    Omena J, Voll VM, Bezerra FF, Braz BF, Santelli RE, Donangelo CM, Jauregui GF, Ribeiro AS, Cople Rodrigues CDS, Citelli M.
    Eur J Clin Nutr; 2024 Sep 15; 78(9):801-807. PubMed ID: 38909172
    [Abstract] [Full Text] [Related]

  • 55. Study of serum hepcidin in hereditary hemolytic anemias.
    El Beshlawy A, Alaraby I, Abdel Kader MS, Ahmed DH, Abdelrahman HE.
    Hemoglobin; 2012 Sep 15; 36(6):555-70. PubMed ID: 23088733
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Alpha-lipoic acid modifies oxidative stress parameters in sickle cell trait subjects and sickle cell patients.
    Martins VD, Manfredini V, Peralba MC, Benfato MS.
    Clin Nutr; 2009 Apr 15; 28(2):192-7. PubMed ID: 19231043
    [Abstract] [Full Text] [Related]

  • 58. Lack of correlation between iron overload cardiac dysfunction and needle liver biopsy iron concentration.
    Berdoukas V, Dakin C, Freema A, Fraser I, Aessopos A, Bohane T.
    Haematologica; 2005 May 15; 90(5):685-6. PubMed ID: 15921384
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Nontransferrin-bound iron in transfused patients with sickle cell disease.
    Inati A, Musallam KM, Cappellini MD, Duca L, Taher AT.
    Int J Lab Hematol; 2011 Apr 15; 33(2):133-7. PubMed ID: 21382180
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.